Overview Fundamentals API Earnings EOD API Sample Code Pricing

Qualigen Therapeutics Inc (QLGN NASDAQ) stock market data APIs

$0.3404 0.03(9.7%) as of July 17, 2024
Price chart is built with Anychart

Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Qualigen Therapeutics Inc Financial Data Overview

3 196 K
9 614 K
4 984 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'QLGN',
Type: 'Common Stock',
Name: 'Qualigen Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG008D03RS4',
CIK: '1460702',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2015-06-24',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Qualigen Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 984 K
  • EBITDA -10 128 838
  • Earnings Per Share -2.16
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Qualigen Therapeutics Inc Earnings via APIs

  • Latest Release 2024-04-08
  • EPS/Forecast NaN

Get Qualigen Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?